Perth's Sir Charles Gairdner Hospital manages myeloma and lymphoma patients requiring proteasome inhibitor therapy. Bortenat 3.5mg provides identical treatment to brand Velcade at significantly reduced cost for Western Australian patients and institutions.
Perth oncology pharmacies can access Bortenat with full WHO-GMP documentation, offering substantial savings on this essential combination therapy component.
|
FAQ: Can Bortenat be used for lymphoma types other than
mantle cell lymphoma? While Bortezomib (Bortenat)
has specific approval for mantle cell lymphoma and multiple myeloma, it is
sometimes used off-label in other lymphoma subtypes as part of clinical
research or specialist-guided treatment plans, particularly in relapsed or
refractory settings. This would always be a specialist oncologist's decision
based on your specific lymphoma type and prior treatment history. |
